⌘K

Login Start Free

Home/Filings/4/0001209191-19-026968

4//SEC Filing

Dwyer Wendy 4

Accession 0001209191-19-026968

CIK 0001718108other

View on SEC.gov Company Profile

Filed

May 1, 8:00 PM ET

Accepted

May 2, 4:04 PM ET

Size

5.4 KB

Accession

0001209191-19-026968

Insider Transaction Report

Form 4

Period: 2019-05-01

Surface Oncology, Inc.SURF

Chief Business Officer

Transactions

Award
Stock Option (Right to Buy)
2019-05-01+125,000→ 125,000 total
Exercise: $4.77Exp: 2029-05-01→ Common Stock (125,000 underlying)

Footnotes (1)

[F1]25% of this option shall become exercisable on April 1, 2020 and the remaining 75% shall vest in 36 equal monthly installments thereafter.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Surface Oncology, Inc.

CIK 0001718108

Entity typeother

Related Parties

1

filerCIK 0001771182

Filing Metadata

Form type: 4
Filed: May 1, 8:00 PM ET
Accepted: May 2, 4:04 PM ET
Size: 5.4 KB

View on SEC.gov